Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. MOZOBIL (plérixafor)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

MOZOBIL (plérixafor)

Medicine - Posted on Mar 18 2020 - Updated on Mar 18 2020
Active substance (DCI)
  • plérixafor
history (3)
  • 3/4/20

    MOZOBIL (plérixafor)

    Key points Favourable opinion for reimbursement in combination with granulocyte-colony stimulating factor (G-CSF) to enhance...
    CAV :
    54321
    icône flèche
  • 12/17/14

    MOZOBIL (plérixafor)

    MOZOBIL (plérixafor)
    CAV :
    54321
    icône flèche
  • 12/16/09

    MOZOBIL

    En association au G-CSF, progrès thérapeutique modéré dans certains lymphomes ou myélomes multiples MOZOBIL est indiqué en a...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • L03AX16
Manufacturer
SANOFI-AVENTIS FRANCE
Presentation

MOZOBIL 20 mg/ml, solution pour injection (code CIS : 60148167)
1 flacon(s) en verre de 1,2 ml (CIP : 34009 397 153 7 7)

All our publications
    Cancers - miscellaneous Drug therapy Hematologic cancers Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
1JkgTW9ZZe9VGfNV